Skin Cancer

Jeffrey S. Weber MD PhD reviews key skin cancer findings presented at the 2017 American Society of Clinical Oncology Annual Meeting.

Share

Program Content

Activities

  • ECHO-202/KEYNOTE-037
    Phase I/II ECHO-202/KEYNOTE-037: Safety of Epacadostat + Pembrolizumab in Solid Tumors
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2017

    Expires: June 04, 2018

  • KEYNOTE-006
    KEYNOTE-006: Long-term Outcomes After Pembrolizumab for Advanced Melanoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2017

    Expires: June 04, 2018

  • CheckMate 204: Nivolumab + Ipilimumab
    CheckMate 204: Nivolumab + Ipilimumab in Pts With Advanced Melanoma and Asymptomatic, Untreated Brain Metastases
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2017

    Expires: June 06, 2018

  • ECHO-204: Epacadostat/Nivo
    ECHO-204: Preliminary Results of Phase I/II Trial of Epacadostat + Nivolumab in Advanced Solid Tumors
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 09, 2017

    Expires: June 08, 2018

  • Ipi ± T-VEC in Melanoma
    Phase II Trial of Ipilimumab ± Talimogene Laherparepvec in Unresected Stage IIIB-IV Melanoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology